Equity research analysts and market consensus models tracking RPG Life Sciences project a 12-month target price centering around ₹2,750, with bull-case targets reaching up to ₹3,350 and bear-case downside scenarios near ₹1,850. These targets reflect anticipated earnings delivery, margin improvements, and potential re-rating catalysts across the healthcare and pharmaceutical formulations sector.
Greenply Industries and Greenpanel Industries are distinct, publicly listed corporate entities, though they share a historical lineage. Greenpanel was originally the Medium Density Fiberboard (MDF) division of Greenply Industries. It was strategically demerged into an independent corporate entity to allow each company to scale its respective operations independently—Greenply focusing primarily on traditional plywood manufacturing and Greenpanel specializing in MDF panels.